Search Results - "Ratsch, Boris A"

Refine Results
  1. 1

    Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas by NAYLOR, Tara L, HUAPING TANG, YAO, Yung-Mae, WARMUTH, Markus, LENZ, Georg, STEGMEIER, Frank, RATSCH, Boris A, ENNS, Andreas, LOO, Alice, LIQING CHEN, LENZ, Peter, WATERS, Nigel J, SCHULER, Walter, DÖRKEN, Bernd

    Published in Cancer research (Chicago, Ill.) (01-04-2011)
    “…The activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) correlates with poor prognosis. The ABC subtype of DLBCL is associated with…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman by Al Baqlani, Said Ali, Sy, Bui Tien, Ratsch, Boris A, Al Naamani, Khalid, Al Awaidy, Salah, Busaidy, Suleiman Al, Pauli, Georg, Bock, C-Thomas

    Published in PloS one (16-05-2014)
    “…Hepatitis B virus (HBV) infection is a major global health burden with distinct geographic public health significance. Oman is a country with intermediate HBV…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database by Scheid, Christof, Blau, Igor W., Sellner, Leopold, Ratsch, Boris A., Basic, Edin

    Published in European journal of haematology (01-02-2021)
    “…Objectives Emerging treatments for relapsed or refractory multiple myeloma (rrMM) have led to increasing options for many patients. This study aimed to assess…”
    Get full text
    Journal Article
  6. 6

    Real-world biologic treatment and associated cost in patients with inflammatory bowel disease by Brandes, Alina, Groth, Antje, Gottschalk, Fraence, Wilke, Thomas, Ratsch, Boris A, Orzechowski, Hans-Dieter, Fuchs, Andreas, Deiters, Barthold, Bokemeyer, Bernd

    Published in Zeitschrift fur Gastroenterologie (01-07-2019)
    “…This study aimed to describe biologic treatment of German inflammatory bowel disease (IBD) patients, including biologics' dosage, health care resource use, and…”
    Get more information
    Journal Article
  7. 7

    Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany by Basic, Edin, Kappel, Mathias, Misra, Arpit, Sellner, Leopold, Ratsch, Boris A., Ostwald, Dennis A.

    Published in The European journal of health economics (01-12-2020)
    “…Background In Germany, several triplet therapies for treating relapsed or refractory multiple myeloma (rrMM) patients have recently been approved. While most…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer? by Wilke, Thomas, Mueller, Sabrina, Bauer, Sabine, Pitura, Silvia, Probst, Leona, Ratsch, Boris A, Salwender, Hans

    Published in Patient preference and adherence (01-01-2018)
    “…This study describes preferences of German relapsed refractory multiple myeloma (RRMM) patients with novel proteasome inhibitor-based combination treatments…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Differential regulation and impact of fucosyltransferase VII and core 2 β1,6‐N‐acetyl‐glycosaminyltransferase for generation of E‐selectin and P‐selectin ligands in murine CD4+ T cells by Schroeter, Micha F., Ratsch, Boris A., Lehmann, Jeanette, Baumgrass, Ria, Hamann, Alf, Syrbe, Uta

    Published in Immunology (01-12-2012)
    “…Summary Ligands for E‐selectin and P‐selectin (E‐lig and P‐lig) are induced on CD4+ T cells upon differentiation into effector T cells. Glycosyltransferases,…”
    Get full text
    Journal Article
  12. 12

    Differential regulation and impact of fucosyltransferase VII and core 2 beta 1,6-N-acetyl-glycosaminyltransferase for generation of E-selectin and P-selectin ligands in murine CD4+ T cells by Schroeter, Micha F, Ratsch, Boris A, Lehmann, Jeanette, Baumgrass, Ria, Hamann, Alf, Syrbe, Uta

    Published in Immunology (01-12-2012)
    “…Ligands for E-selectin and P-selectin (E-lig and P-lig) are induced on CD4+ T cells upon differentiation into effector T cells. Glycosyltransferases,…”
    Get full text
    Journal Article
  13. 13

    Identification of two regulatory elements controlling Fucosyltransferase 7 transcription in murine CD4+ T cells by Pink, Matthias, Ratsch, Boris A., Mardahl, Maibritt, Schröter, Micha F., Engelbert, Dirk, Triebus, Julia, Hamann, Alf, Syrbe, Uta

    Published in Molecular immunology (01-11-2014)
    “…•Murine CD4+ T effector cells express different Fut7 transcripts.•A minimal promoter is located intragenic upstream of exon 4.•A CNS upstream of Fut7 acts as…”
    Get full text
    Journal Article
  14. 14

    The Use of Microarray Technologies in Mantle Cell Lymphoma by Ratsch, Boris A, Grau, Michael, Dörken, Bernd, Lenz, Peter, Lenz, Georg

    Published in Seminars in hematology (01-07-2011)
    “…Mantle cell lymphoma (MCL) is characterized by adverse prognosis and the development of novel therapeutic approaches is essential to improve outcome. The…”
    Get full text
    Journal Article
  15. 15

    Long-Term Commitment to Inflammation-Seeking Homing in CD4+ Effector Cells by Jennrich, Silke, Ratsch, Boris A, Hamann, Alf, Syrbe, Uta

    Published in The Journal of immunology (1950) (15-06-2007)
    “…Access of T effector cells to sites of inflammation is a prerequisite for an efficient action in immune defense and is mediated by different, partly…”
    Get full text
    Journal Article
  16. 16

    Differential regulation and impact of fucosyltransferase VII and core 2 β1,6‐ N ‐acetyl‐glycosaminyltransferase for generation of E ‐selectin and P ‐selectin ligands in murine CD 4 + T cells by Schroeter, Micha F., Ratsch, Boris A., Lehmann, Jeanette, Baumgrass, Ria, Hamann, Alf, Syrbe, Uta

    Published in Immunology (01-12-2012)
    “…Summary Ligands for E ‐selectin and P ‐selectin ( E ‐lig and P ‐lig) are induced on CD 4 + T cells upon differentiation into effector T cells…”
    Get full text
    Journal Article
  17. 17

    Differential regulation and impact of fucosyltransferase VII and core 2 [beta]1,6-N-acetyl-glycosaminyltransferase for generation of E-selectin and P-selectin ligands in murine CD4+ T cells by Schroeter, Micha F, Ratsch, Boris A, Lehmann, Jeanette, Baumgrass, Ria, Hamann, Alf, Syrbe, Uta

    Published in Immunology (01-12-2012)
    “…Summary Ligands for E-selectin and P-selectin (E-lig and P-lig) are induced on CD4+ T cells upon differentiation into effector T cells. Glycosyltransferases,…”
    Get full text
    Journal Article
  18. 18

    Long-Term Commitment to Inflammation-Seeking Homing in CD4 super(+) Effector Cells by Jennrich, Silke, Ratsch, Boris A, Hamann, Alf, Syrbe, Uta

    Published in Journal of Immunology (01-06-2007)
    “…Access of T effector cells to sites of inflammation is a prerequisite for an efficient action in immune defense and is mediated by different, partly…”
    Get full text
    Journal Article
  19. 19

    Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman: e97759 by Baqlani, Said AliAl, Sy, Bui Tien, Ratsch, Boris A, Naamani, Khalid Al, Awaidy, Salah Al, Busaidy, Suleiman Al, Pauli, Georg, Bock, C-Thomas

    Published in PloS one (01-05-2014)
    “…Background Hepatitis B virus (HBV) infection is a major global health burden with distinct geographic public health significance. Oman is a country with…”
    Get full text
    Journal Article
  20. 20

    High Prevalence and Significance of Hepatitis D Virus Infection among Treatment-Naive HBsAg-Positive Patients in Northern Vietnam: e78094 by Sy, Bui Tien, Ratsch, Boris A, Toan, Nguyen Linh, Song, Le Huu, Wollboldt, Christian, Bryniok, Agnes, Nguyen, Hung Minh, Luong, Hoang Van, Velavan, Thirumalaisamy P, Wedemeyer, Heiner

    Published in PloS one (01-10-2013)
    “…Background Hepatitis D virus (HDV) infection is considered to cause more severe hepatitis than hepatitis B virus (HBV) monoinfection. With more than 9.5…”
    Get full text
    Journal Article